These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


81 related items for PubMed ID: 2736515

  • 1. Therapeutic perturbation of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors.
    Miller BE, Miller FR, Heppner GH.
    Cancer Res; 1989 Jul 15; 49(14):3747-53. PubMed ID: 2736515
    [Abstract] [Full Text] [Related]

  • 2. Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors.
    Miller BE, Miller FR, Wilburn D, Heppner GH.
    Cancer Res; 1988 Oct 15; 48(20):5747-53. PubMed ID: 3167832
    [Abstract] [Full Text] [Related]

  • 3. Rates of development of methotrexate resistance in heterogeneous mouse mammary tumor cell cultures.
    Miller BE, Matherly LH, Lehotan M, Heppner GH.
    J Exp Ther Oncol; 1996 Jan 15; 1(1):30-8. PubMed ID: 9414386
    [Abstract] [Full Text] [Related]

  • 4. Tumor subpopulation interactions affecting melphalan sensitivity in palpable mouse mammary tumors.
    Miller BE, Machemer T, Lehotan M, Heppner GH.
    Cancer Res; 1991 Aug 15; 51(16):4378-87. PubMed ID: 1868461
    [Abstract] [Full Text] [Related]

  • 5. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC.
    Clin Cancer Res; 2000 May 15; 6(5):2028-36. PubMed ID: 10815929
    [Abstract] [Full Text] [Related]

  • 6. A dominated and resistant subpopulation causes regrowth after response to 1,3-bis(2-chloroethyl)-1-nitrosourea treatment of a heterogeneous small cell lung cancer xenograft in nude mice.
    Aabo K, Roed H, Vindeløv LL, Spang-Thomsen M.
    Cancer Res; 1994 Jun 15; 54(12):3295-9. PubMed ID: 8205552
    [Abstract] [Full Text] [Related]

  • 7. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy.
    Emerman JT, Siemiatkowski J.
    Cancer Res; 1984 Apr 15; 44(4):1327-32. PubMed ID: 6704951
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
    Heppner GH, Dexter DL, DeNucci T, Miller FR, Calabresi P.
    Cancer Res; 1978 Nov 15; 38(11 Pt 1):3758-63. PubMed ID: 698935
    [Abstract] [Full Text] [Related]

  • 9. Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor.
    Miller BE, Miller FR, Leith J, Heppner GH.
    Cancer Res; 1980 Nov 15; 40(11):3977-81. PubMed ID: 7471048
    [Abstract] [Full Text] [Related]

  • 10. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS, Miller CH, Graham L, Parviz M, Zacur S, Patel B, Duong A, Bear HD.
    Int Immunol; 2004 Sep 15; 16(9):1283-94. PubMed ID: 15262898
    [Abstract] [Full Text] [Related]

  • 11. Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures.
    Miller BE, Miller FR, Heppner GH.
    Cancer Res; 1985 Sep 15; 45(9):4200-5. PubMed ID: 4028010
    [Abstract] [Full Text] [Related]

  • 12. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET, Kelley M, Rockwell S.
    Cancer Chemother Pharmacol; 2004 Jan 15; 53(1):43-50. PubMed ID: 14574460
    [Abstract] [Full Text] [Related]

  • 13. Growth regulation of mouse mammary tumor cells in collagen gel cultures by diffusible factors produced by normal mammary gland epithelium and stromal fibroblasts.
    Miller FR, McEachern D, Miller BE.
    Cancer Res; 1989 Nov 01; 49(21):6091-7. PubMed ID: 2790822
    [Abstract] [Full Text] [Related]

  • 14. Effects of repeated exposure to cyclophosphamide on drug resistance and biological properties of a newly autonomy-acquired mouse mammary tumor (T4-OI320).
    Takeda Y, Matsuzawa A, Kaneko T, Sekiguchi M, Fujii G.
    Jpn J Exp Med; 1988 Apr 01; 58(2):87-98. PubMed ID: 2842525
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma.
    Alonso DF, Farías EF, Urtreger A, Ladeda V, Vidal MC, Bal De Kier Joffé E.
    J Surg Oncol; 1996 Aug 01; 62(4):288-97. PubMed ID: 8691844
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.